Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2005
12/08/2005US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole
12/08/2005US20050272789 Triazole-derived kinase inhibitors and uses thereof
12/08/2005US20050272785 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272778 Inhibitors of proteins that bind phosphorylated molecules
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272734 Aids therapy
12/08/2005US20050272728 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272663 Novel substituted prolines as inhibitors of hepatitis C virus NS3 serine protease
12/08/2005US20050272036 Ketones
12/08/2005US20050271669 For therapy of proliferative disease
12/08/2005CA2568742A1 Substituted thiazoleacetic as crth2 ligands
12/08/2005CA2568578A1 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567703A1 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
12/08/2005CA2566094A1 Cinnamide compound
12/08/2005CA2566051A1 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders
12/08/2005CA2565486A1 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/08/2005CA2564638A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders
12/08/2005CA2564139A1 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders
12/08/2005CA2563818A1 Compounds and compositions as ppar modulators
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602373A1 Ocular hypotensive agent
12/07/2005EP1601671A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
12/07/2005EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
12/07/2005EP1601653A1 Process for the production of substituted nicotinic acid esters
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1175410B1 Pesticidal triazine derivatives
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705663A Acyl derivatives of 5-(2-(4-(1,2 benzisothiazole-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one having neuroleptic activity
12/07/2005CN1705662A Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
12/07/2005CN1705645A Methylene urea derivatives as raf-kinase inhibitors
12/07/2005CN1705636A Process for converting a cis-trans mixture of substituted benzylidene amines into the pure cis isomer
12/07/2005CN1230435C Heteroaryl-substd. heterocycles
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972297 2-Hydroxy-mutilin carbamate derivatives for antibacterial use
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972286 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/05/2005WO2005116054A1 Process for preparing acyclic hcv protease inhibitors
12/05/2005CA2568008A1 Process for preparing acyclic hcv protease inhibitors
12/01/2005WO2005113581A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005WO2005113551A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/01/2005WO2005113550A1 Aminopyrimidine derivative and medicinal use thereof
12/01/2005WO2005113548A1 Thiophene heteroaryl amines
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113526A2 Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113504A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005WO2005112938A2 Disalt inhibitors of il-12 production
12/01/2005WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication
12/01/2005WO2005090383A3 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections
12/01/2005WO2005085240A3 Process for the preparation of ziprasidone
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005WO2004080964A8 Indole derivatives useful for the treatment of diseases
12/01/2005US20050267200 Heteroaromate OSC inhibitors
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267173 Serine protease inhibitors
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267162 Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
12/01/2005US20050267160 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
12/01/2005US20050267156 Broadspectrum 2-amino-benzothiazole sulfonamide hiv protease inhibitors
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267151 Hepatitis C; preparing 8-bromo-7-alkoxyquinolines 2-substituted with a hetercyclic ring having an amine, carbamate, amine or urea group an 4-substituted with a 3-prolineoxy- group or derivative; intermediates
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267104 Acyloxymethylcarbamate prodrugs of oxazolidinones
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005CA2567404A1 Cyclopenta[b]benzofuran derivatives and the utilization thereof
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2567228A1 Thiophene heteroaryl amines
12/01/2005CA2566610A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005CA2564076A1 Chemical linkers and conjugates thereof
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
1 ... 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 ... 628